Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06506721

Comparison Between Two Medical Devices for Labor Induction After Previous C-section

The objective of the study ist to compare the Dilapan-S and the Cook Ballon device for the mechanical induction of labour in women with a previous C-section. There is currently lack of data regarding this comparison of the two methods for mechanical labour induction in this patient collective. Any method used for labour induction is therefore off-label. The primary outcome is the time between placement of the device and delivery. Ad secondary outcomes are among others the cesarean delivery rate and patient satisfaction with the induction method.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–60 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

University Hospital of Obstetrics and Gynäkologie, Inselspital

Bern, 3010, Switzerland

Location status: Recruiting

Location contact

Anda P Radan, PD Dr. med.

CONTACT

[email protected]

0041/ 0316321010

Daniel Surbek, Prof. Dr.

PRINCIPAL_INVESTIGATOR

Mihaela M Fluri, Dr. med. univ.

CONTACT

[email protected]

0041/ 0316321010

About this study

The cesarean section (CS) rate is increasing worldwide, with previous CS being an important factor contributing to this trend. The investigators think that VBAC may be safe, provided a careful selection of the patients is performed. The individual birth management is particularly important if labour has to be induced, as in case of approximately 25% of women attempting VBAC. Counselling patients about labour induction can be challenging, as they should be offered not only a safe, but also an effective method. Labor induction can be achieved by using several approaches: administration of drugs, which induce uterine contractions, such as prostaglandins or oxytocin, performing an amniotomy, or using mechanical methods. In Switzerland and implicitly in the investigators' institution, PGE after CS are rarely employed in carefully selected cases. Oxytocin administration after performing amniotomy is considered to be a safe method, but may be less effective with an unfavorable BISHOP score (<6).

An possible alternative in case of unripe cervix is induction of labour by use of mechanical methods: balloon catheters and laminaria stents. The investigators currently use the double balloon catheter device (Cook Inc) for this purpose. This device is inserted transcervically and both ballons are inflated with sterile 0.9% saline solution. The catheter remains in place until spontaneously expelled or until start of active labour. If neither happens, it will be removed after 12 hours, followed by oxytocin administration and amniotomy.

Recently, an alternative method for mechanical induction is gaining increased attention: the use of hygroscopic cervical dilators. The method seems to be equally effective and safe as directly compared to a single device catheter in a low risk population of women without uterine scar. When used in patients with previous cesarean section, the rate of spontaneous labour seems to resemble existent data for induction with balloon catheter, this including the investigators' collective.

One of the advantages of Dilapan-S® could be the lack of vaginal protrusion and the fact that it does not have to be fixated under tension. Women seem to feel more mobile with Dilapan®, the perception of relaxation moments between contractions as well as sleep periods during the induction seem to be improved with Dilapan®.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All women >= 18years old with a previous CS and an indication of labour induction, between 24-42 weeks of pregnancy.
  • Modified Bishop-Score < 6
  • Informed consent

Exclusion criteria

  • More than 1 CS
  • Premature rupture of membranes
  • Vaginal infection
  • Intrauterine fetal demise
  • Twin pregnancy
  • Contraindication against labour induction or vaginal delivery
  • Vaginal bleeding
  • Simultaneous external administration of prostaglandins planned
  • Placenta praevia, vasa praevia or placenta accreta spectrum
  • Transverse fetal orientation
  • Prolapsed umbilical cord
  • Prior hysterotomy, classic uterine incision, myomectomy or any other full thickness uterine incision (except C-section)
  • Pelvic structural anomaly
  • Active genital herpes infection
  • Invasive cervical cancer
  • Abnormal fetal heart rate pattern
  • Breech presentation
  • Maternal heart disease
  • Polyhydramnios
  • Presentic part above the pelvic inlet
  • Severe maternal hypertension

Treatment and study plan

Double ballon device, Cook

Device

Cook double balloon will be introduced transcervically. The double balloon will be inflated with sterile 0-9% saline solution (maximum 80 ml in each balloon of the double device), then the catheter will be fixed with a tape at the women's thigh without traction. The catheter will remain in place until spontaneously expelled or start of active labour.

If neither happens, the device will be removed after 12-24 hours and oxytocin will be administered and amniotomy as soon as feasible. If the cervix remains unfavorable after two cycles of 6 hours of oxytocin infusion, the induction will be classified as unsuccessful and C-section will be performed.

Hygroscopic cervix dilators, Dilapan-S

Device

A maximum number of 5 hygroscopic cervical dilator rods will be inserted transcervically, after humidification with sterile 0.9% saline solution. They will be fixed in this position by inserting a humidified compress into the vagina. They will remain in place until spontaneously expelled or until start of active labour.

In neither happens, the devices will be removed after 12-24 hours and oxytocin will be administered and amniotomy as soon as feasible. If the cervix remains unfavorable after two cycles of 6 hours of oxytocin infusion, the induction will be classified as unsuccessful and C-section will be performed.

Primary outcomes

  1. Induction-to-delivery interval (IDI) after induction of labour (COOK catheter or Dilapan) in women with previous CS.

    Time frame: 72 hours

    The time between placement of the device and delivery

Secondary outcomes

  1. Cesarean delivery rate

    Time frame: 72 hours

    How many women will get at the end a C-section after inducing the labour

  2. Neonatal outcomes

    Time frame: 2 hours

    The cord arterial pH (< 7.10)

  3. Neonatal outcomes

    Time frame: 2 hours

    5 minutes APGAR-Score (< 7)

  4. Neonatal outcomes

    Time frame: 2 hours

    Transfer to the ICU

  5. Maternal infection rate

    Time frame: 96 hours

    To asses the maternal infection status the investigators use the temperature (fever >38.0°), Leucocytosis (> 16.000 G/l), CRP (> 50)

  6. Patient satisfaction

    Time frame: 96 hours

    All participant will receive a questionnaire after birth regarding the time from induction initiation until active phase of labour, covering questions such as convenience of the induction method (multiplicity of vaginal manipulation, comfort and pain experience)

Study contacts

Contact information is provided by the study sponsor or research team.

Anda P Radan, PD Dr. med.

CONTACT

[email protected]

+41/0316321010

Mihaela M Fluri, Dr. med.univ.

CONTACT

[email protected]

+41/0316321010

Sponsors and collaborators

Lead sponsor

Insel Gruppe AG, University Hospital Bern

Other

Registry information

Official study title

Balloon Catheter vs. Hygroscopic Cervical Dilator for Labour Induction After Previous Caesarean Section: an Open Prospective Randomized Controlled Trial

Acronym: DiBal

Important dates

Study start
2023
Primary completion
2026
Study completion
2026
First posted
Jul 17, 2024
Registry last updated
Jan 14, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.